The FDA hasn't approved tirzepatide for prediabetes, and Medicaid programs rarely cover off-label use of high-cost medications
In some instances, healthcare providers prescribe Ozempic for weight loss, though this was not its original purpose
When selecting antidiabetic therapies, consider the liver dimension: some drug classes (GLP-1 RAs, SGLT2i, TZDs) may provide dual benefits
A: Yes, though caution is advised with blood thinners or CNS-active substances
HbA 1c change and diabetic retinopathy during GLP-1 receptor agonist cardiovascular outcome trials: a meta-analysis and meta-regression
Konopleva M, Mikhail A, Estrov Z, Zhao S, Harris D, Sanchez-Williams G, Kornblau S, Jung J, Kliche KO, Jiang S, Przepiorka D, Snodgrass HR, Estey E, Andreeff M